转移性结直肠癌-话题@MedSci

#转移性结直肠癌#

5篇内容 | 3003人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=2173990, encodeId=82f521e399031, content=<a href='/topic/show?id=6b058150307' target=_blank style='color:#2F92EE;'>#肝转移#</a> <a href='/topic/show?id=18d293422fd' target=_blank style='color:#2F92EE;'>#转移性结直肠癌#</a>, objectTitle=EJC：肝转移显著降低dMMR转移性结直肠癌患者一线免疫治疗的疗效！, objectType=article, longId=804397, objectId=b77e80439e44, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/Random/medics-and-patient-on-hospital-gurney-at-PMW6NAQ.jpg, objectUrl=/article/show_article.do?id=b77e80439e44, replyNumber=0, likeNumber=121, createdTime=2023-12-10, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=b77e80439e44, moduleTitle=EJC：肝转移显著降低dMMR转移性结直肠癌患者一线免疫治疗的疗效！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b77e80439e44)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2172074, encodeId=e6ca21e2074a0, content=<a href='/topic/show?id=e070105e2bb' target=_blank style='color:#2F92EE;'>#KRAS突变#</a> <a href='/topic/show?id=18d293422fd' target=_blank style='color:#2F92EE;'>#转移性结直肠癌#</a> <a href='/topic/show?id=9841e70051' target=_blank style='color:#2F92EE;'>#FTD/TPI#</a>, objectTitle=读书报告 | KRAS突变位点可预测FTD/TPI治疗转移性结直肠癌的生存获益风险, objectType=article, longId=802950, objectId=d996802950f5, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/Random/patient-meeting-a-doctor-PAYSRMZ.jpg, objectUrl=/article/show_article.do?id=d996802950f5, replyNumber=0, likeNumber=129, createdTime=2023-11-30, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=d996802950f5, moduleTitle=读书报告 | KRAS突变位点可预测FTD/TPI治疗转移性结直肠癌的生存获益风险, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d996802950f5)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2171668, encodeId=741d21e1668a1, content=<a href='/topic/show?id=18d293422fd' target=_blank style='color:#2F92EE;'>#转移性结直肠癌#</a> <a href='/topic/show?id=7bba10e99631' target=_blank style='color:#2F92EE;'>#微卫星稳定#</a> <a href='/topic/show?id=47ec10e99767' target=_blank style='color:#2F92EE;'>#信迪利单抗联#</a>, objectTitle=读书报告 | 信迪利单抗联合贝伐单抗/奥沙利铂/卡培他滨一线治疗RAS 突变微卫星稳定MSS的不可切除的转移性结直肠癌II 期临, objectType=article, longId=802665, objectId=6a4980266574, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/202301009/1696894047941_4754896.jpeg, objectUrl=/article/show_article.do?id=6a4980266574, replyNumber=0, likeNumber=139, createdTime=2023-11-29, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=6a4980266574, moduleTitle=读书报告 | 信迪利单抗联合贝伐单抗/奥沙利铂/卡培他滨一线治疗RAS 突变微卫星稳定MSS的不可切除的转移性结直肠癌II 期临, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6a4980266574)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2170678, encodeId=794121e06789c, content=<a href='/topic/show?id=daf52906537' target=_blank style='color:#2F92EE;'>#免疫治疗#</a> <a href='/topic/show?id=18d293422fd' target=_blank style='color:#2F92EE;'>#转移性结直肠癌#</a> <a href='/topic/show?id=1fd46051ab' target=_blank style='color:#2F92EE;'>#dMMR/MSI-H#</a>, objectTitle=大咖谈 | dMMR/MSI-H 转移性结直肠癌的免疫治疗, objectType=article, longId=802068, objectId=e19380206840, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/Random/patient-meeting-a-doctor-PAYSRMZ.jpg, objectUrl=/article/show_article.do?id=e19380206840, replyNumber=0, likeNumber=146, createdTime=2023-11-24, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=e19380206840, moduleTitle=大咖谈 | dMMR/MSI-H 转移性结直肠癌的免疫治疗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e19380206840)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2117674, encodeId=9b51211e6742e, content=<a href='/topic/show?id=18d293422fd' target=_blank style='color:#2F92EE;'>#转移性结直肠癌#</a><a href='/topic/show?id=c01b2138812' target=_blank style='color:#2F92EE;'>#中医#</a><a href='/topic/show?id=5f089169e38' target=_blank style='color:#2F92EE;'>#诊疗指南#</a>, objectTitle=转移性结直肠癌中医诊疗指南, objectType=guider, longId=22238, objectId=2389e1c0029599a1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/guideline/show_article.do?id=2389e1c0029599a1, replyNumber=0, likeNumber=183, createdTime=2023-03-05, rootId=0, userName=lifestar, userId=aa0e14, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=2389e1c0029599a1, moduleTitle=转移性结直肠癌中医诊疗指南, moduleType=guider, hrefUrl=https://www.medsci.cn/guideline/show_article.do?id=2389e1c0029599a1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2117673, encodeId=7817211e673c3, content=<a href='/topic/show?id=7efe68e26bd' target=_blank style='color:#2F92EE;'>#瑞戈非尼#</a>用于既往治疗过的<a href='/topic/show?id=18d293422fd' target=_blank style='color:#2F92EE;'>#转移性结直肠癌#</a><a href='/topic/show?id=493ae869206' target=_blank style='color:#2F92EE;'>#结直肠癌#</a>, objectTitle=2023 NICE 技术鉴定指导意见：瑞戈非尼用于既往治疗过的转移性结直肠癌[TA866], objectType=guider, longId=22282, objectId=b94ac1c00296a3b8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/guideline/show_article.do?id=b94ac1c00296a3b8, replyNumber=0, likeNumber=144, createdTime=2023-03-05, rootId=0, userName=lifestar, userId=aa0e14, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=b94ac1c00296a3b8, moduleTitle=2023 NICE 技术鉴定指导意见：瑞戈非尼用于既往治疗过的转移性结直肠癌[TA866], moduleType=guider, hrefUrl=https://www.medsci.cn/guideline/show_article.do?id=b94ac1c00296a3b8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1220490, encodeId=c04f1220490e2, content=<a href='/topic/show?id=7efe68e26bd' target=_blank style='color:#2F92EE;'>#瑞戈非尼#</a>联合<a href='/topic/show?id=4e9ae7349f2' target=_blank style='color:#2F92EE;'>#纳武单抗#</a>治疗<a href='/topic/show?id=18d293422fd' target=_blank style='color:#2F92EE;'>#转移性结直肠癌#</a><a href='/topic/show?id=493ae869206' target=_blank style='color:#2F92EE;'>#结直肠癌#</a>, objectTitle=Eur J Cancer：瑞戈非尼联合纳武单抗治疗转移性结直肠癌, objectType=article, longId=727120, objectId=36ade27120a4, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20220516/1652695606423_2110107.JPG, objectUrl=/article/show_article.do?id=36ade27120a4, replyNumber=0, likeNumber=190, createdTime=2022-05-17, rootId=0, userName=赛华佗, userId=7a3710, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=36ade27120a4, moduleTitle=Eur J Cancer：瑞戈非尼联合纳武单抗治疗转移性结直肠癌, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=36ade27120a4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=800557, encodeId=8f3380055e02, content=<a href='/topic/show?id=18d293422fd' target=_blank style='color:#2F92EE;'>#转移性结直肠癌#</a>, objectTitle=Fruquintinib治疗转移性结直肠癌：美国FDA授予快速通道称号, objectType=article, longId=196107, objectId=b8dd19610eb8, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/2020618/1592485620172_5295902.jpeg, objectUrl=/article/show_article.do?id=b8dd19610eb8, replyNumber=0, likeNumber=195, createdTime=2020-06-30, rootId=0, userName=mswert122, userId=2a791737770, projectId=1, avatar=https://cdnapi.center.medsci.cn/medsci/head/2017/02/28/889a1910ded7780f3c049b354f1648b7.jpg, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b8dd19610eb8, moduleTitle=Fruquintinib治疗转移性结直肠癌：美国FDA授予快速通道称号, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b8dd19610eb8)], followStatus=false, userIsMember=true, type=1, lengthMark=0)] 梅斯话题小助手

转移性结直肠癌

2020-05-29发表于威斯康星

梅斯管理员 (审核中...)

前往app查看评论内容

#肝转移# #转移性结直肠癌#

EJC：肝转移显著降低dMMR转移性结直肠癌患者一线免疫治疗的疗效！

2023-12-10发表于上海

梅斯管理员 (审核中...)

前往app查看评论内容

#KRAS突变# #转移性结直肠癌# #FTD/TPI#

读书报告 | KRAS突变位点可预测FTD/TPI治疗转移性结直肠癌的生存获益风险

2023-11-30发表于上海

梅斯管理员 (审核中...)

前往app查看评论内容

#转移性结直肠癌# #微卫星稳定# #信迪利单抗联#

读书报告 | 信迪利单抗联合贝伐单抗/奥沙利铂/卡培他滨一线治疗RAS 突变微卫星稳定MSS的不可切除的转移性结直肠癌II 期临

2023-11-29发表于上海

梅斯管理员 (审核中...)

前往app查看评论内容

#免疫治疗# #转移性结直肠癌# #dMMR/MSI-H#

大咖谈 | dMMR/MSI-H 转移性结直肠癌的免疫治疗

2023-11-24发表于上海

lifestar (审核中...)

前往app查看评论内容

#转移性结直肠癌##中医##诊疗指南#

转移性结直肠癌中医诊疗指南

2023-03-05发表于上海

lifestar (审核中...)

前往app查看评论内容

#瑞戈非尼#用于既往治疗过的#转移性结直肠癌##结直肠癌#

2023 NICE 技术鉴定指导意见：瑞戈非尼用于既往治疗过的转移性结直肠癌[TA866]

2023-03-05发表于上海

赛华佗 (审核中...)

前往app查看评论内容

#瑞戈非尼#联合#纳武单抗#治疗#转移性结直肠癌##结直肠癌#

Eur J Cancer：瑞戈非尼联合纳武单抗治疗转移性结直肠癌

2022-05-17

(审核中...)

前往app查看评论内容

#转移性结直肠癌#

Fruquintinib治疗转移性结直肠癌：美国FDA授予快速通道称号

2020-06-30

科室
- - 订阅+
  - 更多科室
工具
服务